A host-guest approach for determining drug-DNA interactions: an example using netropsin

Area of Science:

• Structural Biology
• Biochemistry
• Molecular Biology

Background:

• Netropsin is a model compound for studying drug-DNA interactions.
• Understanding drug-DNA binding is crucial for therapeutic development.
• Previous studies provide limited insight into netropsin's precise binding orientation.

Purpose of the Study:

• To investigate the structural basis of netropsin binding to DNA using a novel host-guest approach.
• To determine the structure of a netropsin-DNA complex at high resolution.
• To elucidate how DNA minor groove asymmetry affects netropsin orientation.

Main Methods:

• Co-crystallization of a host-guest system involving the N-terminal fragment of Moloney murine leukemia virus reverse transcriptase (MMLV RT) and a DNA oligonucleotide.
• X-ray crystallography to determine the structure of the netropsin-RT-DNA complex at 1.85 A resolution.
• Comparative analysis of the determined structure with existing Class I netropsin-DNA structures.

Main Results:

• The crystal structure of netropsin bound to an MMLV RT-DNA complex was determined.
• The DNA oligonucleotide contained asymmetric flanking sequences around the AATT binding sites.
• Netropsin's guanidinium and amidinium moieties occupied different minor groove widths, influencing its orientation.
• Asymmetry in the DNA minor groove width was identified as a key factor in netropsin's orientation.

Conclusions:

• The study provides high-resolution structural insights into netropsin-DNA interactions.
• DNA minor groove asymmetry dictates netropsin's binding orientation.
• This host-guest approach offers a novel method for studying drug-DNA interactions.